Lauren M. Zhao, BA
Articles
April 13th 2021
Two Steps Forward, One Step Back: 50 Years of Societal Value From LDL-C–Lowering Therapies
Joanna P. MacEwan, PhD Lauren M. Zhao, BA Katie Everson, MS Larry Liu, MD, PhD Dominik Lautsch, PhD Fang Sun, MD, PhD Darius N. Lakdawalla, PhD
Low-density lipoprotein cholesterol (LDL-C)–lowering therapies have yielded significant value to society through reduced costs for both fatal and nonfatal cardiovascular disease events. The vast majority of this value has accrued to patients.
Latest Updated Articles
Published: May 9th 2024 | Updated: May 21st 2024
FDA Accepts Nivolumab Subcutaneous Injection Application, With Potential to Boost Access to PD-1 Inhibitors
Published: September 12th 2024 | Updated: September 16th 2024
The American Journal of Managed Care® Announces Lisa Rotenstein, M.D., MBA, as the Recipient of the Seema S. Sonnad Emerging Leader in Managed Care Research Award
Published: April 23rd 2024 | Updated: September 16th 2024
The American Journal of Managed Care® Announces Call for Manuscript Submissions for the 14th Annual Health Information Technology Special Issue
Published: August 6th 2024 | Updated: September 16th 2024
Rising Costs Lead Insurers to Drop Weight Loss Drug Coverage, Further Increasing Patient Burden
Published: August 16th 2024 | Updated: September 16th 2024
How Can We Improve Obesity Care in 2024 and Beyond?
Published: September 10th 2024 | Updated: September 16th 2024
Different Options for Different People: Dr Bellinda King-Kallimanis Explores the State of Patient Education in Lung Cancer
